Search research articles
Contact Us
Filters
Showing results (341-350 of 452) with videos related to
Page
of 46
Sort By:
BMC Health Services Research
|
December 23, 2015
Organizational culture in cardiovascular care in Chinese hospitals: a descriptive cross-sectional study
Emily S Yin, Nicholas S Downing, Xi Li, et al.
Tissue Antigens
|
October 31, 2014
Characterization of major histocompatibility complex class I allele polymorphisms in common marmosets
T Li, Y Xu, S Yin, et al.
The Journal of Clinical Investigation
|
March 1, 1994
Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo
T R Ulich, E S Yi, K Longmuir, et al.
European Review for Medical and Pharmacological Sciences
|
August 22, 2023
Is tirzepatide 15 mg the preferred treatment strategy for type 2 diabetes? A meta-analysis and trial-sequence-analysis
X-Y Yang, S Yin, Y-F Yu, et al.
The Pharmacogenomics Journal
|
August 3, 2010
Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery disease
L Zhang, S Yin, K Miclaus, et al.
Zhonghua Nei Ke Za Zhi
|
August 10, 2017
[The clinical safety and efficacy of low dose subcutaneous decitabine in treating acute myeloid leukemia and intermediate- or higer-risk myelodysplastic syndromes in the elderly patients]
H Ai, X D Wei, Q S Yin, et al.
Haematologica
|
September 12, 2000
Screening for (--SEA) alpha-globin gene deletion in beta-thalassemia carriers and prevention of hydrops fetalis
E S Kwan Ma, A Y Yin Chan, S Yin Ha, et al.
Gene Therapy
|
March 27, 2015
Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane
H Jie, S Tao, L Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 17, 2021
[Clinical efficacy and safety of flumatinib combined with multidrug chemotherapy in the treatment of 12 cases with Ph(+) acute lymphoblastic leukemia]
R H Mi, L Chen, H P Yang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Targeted immunotherapy efficacy analysis in patients with relapsed/refractory B cell acute lymphocytic leukemia]
Y Su, S Bao, Y P Wei, et al.
Page
of 46
Search research articles
Search
Showing results (341-350 of 452) with videos related to
Sort By:
Page
of 46
BMC Health Services Research
|
December 23, 2015
Organizational culture in cardiovascular care in Chinese hospitals: a descriptive cross-sectional study
Emily S Yin, Nicholas S Downing, Xi Li, et al.
Tissue Antigens
|
October 31, 2014
Characterization of major histocompatibility complex class I allele polymorphisms in common marmosets
T Li, Y Xu, S Yin, et al.
The Journal of Clinical Investigation
|
March 1, 1994
Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo
T R Ulich, E S Yi, K Longmuir, et al.
European Review for Medical and Pharmacological Sciences
|
August 22, 2023
Is tirzepatide 15 mg the preferred treatment strategy for type 2 diabetes? A meta-analysis and trial-sequence-analysis
X-Y Yang, S Yin, Y-F Yu, et al.
The Pharmacogenomics Journal
|
August 3, 2010
Assessment of variability in GWAS with CRLMM genotyping algorithm on WTCCC coronary artery disease
L Zhang, S Yin, K Miclaus, et al.
Zhonghua Nei Ke Za Zhi
|
August 10, 2017
[The clinical safety and efficacy of low dose subcutaneous decitabine in treating acute myeloid leukemia and intermediate- or higer-risk myelodysplastic syndromes in the elderly patients]
H Ai, X D Wei, Q S Yin, et al.
Haematologica
|
September 12, 2000
Screening for (--SEA) alpha-globin gene deletion in beta-thalassemia carriers and prevention of hydrops fetalis
E S Kwan Ma, A Y Yin Chan, S Yin Ha, et al.
Gene Therapy
|
March 27, 2015
Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane
H Jie, S Tao, L Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
November 17, 2021
[Clinical efficacy and safety of flumatinib combined with multidrug chemotherapy in the treatment of 12 cases with Ph(+) acute lymphoblastic leukemia]
R H Mi, L Chen, H P Yang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Targeted immunotherapy efficacy analysis in patients with relapsed/refractory B cell acute lymphocytic leukemia]
Y Su, S Bao, Y P Wei, et al.
Page
of 46